» Articles » PMID: 38896292

A Label-free and Rapid Fluorometric Strategy for MicroRNA Detection Using CRISPR-Cas12a Coupled with Copper Nanoparticles

Overview
Journal Mikrochim Acta
Specialties Biotechnology
Chemistry
Date 2024 Jun 19
PMID 38896292
Authors
Affiliations
Soon will be listed here.
Abstract

CRISPR-Cas12a with robust trans-cleavage activity were employed to mitigate background fluorescence signal, achieving sensitive detection of miRNA-21. The activation of trans-cleavage activity of Cas12a was achieved by utilizing cDNA as a trigger. Upon the presence of target miRNA-21, cDNA hybridizes with it forming a DNA/RNA double-stranded structure. Exonuclease III (ExoIII) facilitates the degradation of cDNA, releasing the target for subsequent cycles. Due to cDNA degradation, the trans-cleavage activity of Cas12a remains unactivated and does not disrupt the synthesis template of copper nanoparticles. Addition of Cu and AA leads to the formation of highly fluorescent copper nanoparticles. Conversely, in absence of miRNA-21, intact cDNA activates trans-cleavage activity of Cas12a, resulting in degradation of the synthesis template and failure in synthesizing fluorescent copper nanoparticles. This method exhibits excellent selectivity with a low limit of detection (LOD) at 5 pM. Furthermore, we successfully applied this approach to determine miRNA-21 in cell lysates and human serum samples, providing a new approach for sensitive determination of biomarkers in biochemical research and disease diagnosis.

Citing Articles

CRISPR detection of cardiac tumor-associated microRNAs.

Fu Y, Zhang P, Chen F, Xie Z, Xiao S, Huang Z Mol Biol Rep. 2025; 52(1):114.

PMID: 39797940 DOI: 10.1007/s11033-024-10205-4.

References
1.
Tang S, Qi T, Yao Y, Tang L, Chen W, Chen T . Magnetic Three-Phase Single-Drop Microextraction for Rapid Amplification of the Signals of DNA and MicroRNA Analysis. Anal Chem. 2020; 92(18):12290-12296. DOI: 10.1021/acs.analchem.0c01936. View

2.
Bartel D . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. DOI: 10.1016/s0092-8674(04)00045-5. View

3.
Tavazoie S, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos P . Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 2008; 451(7175):147-52. PMC: 2782491. DOI: 10.1038/nature06487. View

4.
Carthew R, Sontheimer E . Origins and Mechanisms of miRNAs and siRNAs. Cell. 2009; 136(4):642-55. PMC: 2675692. DOI: 10.1016/j.cell.2009.01.035. View

5.
Uzuner E, Ulu G, Gurler S, Baran Y . The Role of MiRNA in Cancer: Pathogenesis, Diagnosis, and Treatment. Methods Mol Biol. 2021; 2257:375-422. DOI: 10.1007/978-1-0716-1170-8_18. View